Literature DB >> 10906359

Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology.

D S Thompson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906359     DOI: 10.1176/appi.psy.41.4.356

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  13 in total

1.  Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.

Authors:  Syed I M Thiwan; Douglas A Drossman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

Review 2.  The treatment of depression in cancer patients: a systematic review.

Authors:  Gary Rodin; Nancy Lloyd; Mark Katz; Esther Green; Jean A Mackay; Rebecca K S Wong
Journal:  Support Care Cancer       Date:  2006-10-21       Impact factor: 3.603

3.  Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial.

Authors:  Jun Cao; Quchang Ouyang; Shusen Wang; Joseph Ragaz; Xiaojia Wang; Yuee Teng; Biyun Wang; Zhonghua Wang; Jian Zhang; Leiping Wang; Jiong Wu; Zhimin Shao; Xichun Hu
Journal:  Invest New Drugs       Date:  2020-02-08       Impact factor: 3.850

4.  Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice.

Authors:  Lin Jia; Yuan-Yuan Shang; Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

5.  Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.

Authors:  Eylem Sahin Cankurtaran; Elvan Ozalp; Haldun Soygur; Derya Iren Akbiyik; Levent Turhan; Necati Alkis
Journal:  Support Care Cancer       Date:  2008-02-26       Impact factor: 3.603

Review 6.  [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Authors:  G Benze; B Alt-Epping; A Geyer; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

7.  An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.

Authors:  Mehmet A Ersoy; Aysin M Noyan; Hayriye Elbi
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

8.  Personalizing behavioral interventions: the case of late-life depression.

Authors:  Patricia A Arean
Journal:  Neuropsychiatry (London)       Date:  2012-04

Review 9.  Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines.

Authors:  L Lee Dupuis; Paul C Nathan
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

Review 10.  The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer.

Authors:  Janet Hardy; Mellar P Davis
Journal:  Curr Treat Options Oncol       Date:  2021-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.